Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

nabiximols

An herbal preparation containing a defined quantity of specific cannabinoids formulated for oromucosal spray administration with potential analgesic activity. Nabiximols contains a standardized extract of tetrahydrocannabinol (THC), the non-psychoactive cannabinoid cannabidiol (CBD), other minor cannabinoids, flavonoids, and terpenes from two cannabis plant varieties. Cannabinoids interact with G protein-coupled cannabinoid 1 (CB1) receptors in the central nervous system, resulting in analgesic, euphoric, and anticonvulsive effects.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:cannabidiol mixture with tetrahydrocannabinol
cannabis-based oromucosal spray GW-1000-02
THC and CBD mixture
US brand name:Sativex
Foreign brand name:Sativex
Code name:GW-1000
GW-1000-02
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search